+499.5%
MRNA vs BTG
+38.4%
+461.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BTG | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.4% | -0.8% | -1.4% |
| 7D | +5.5% | -0.9% | +6.4% | +5.4% |
| 30D | +158.7% | +36.8% | +121.9% | +126.9% |
| 3M | +182.1% | +23.1% | +159.0% | +154.4% |
| 6M | +151.8% | +3.5% | +148.3% | +137.6% |
| YTD | +393.6% | +25.5% | +368.1% | +333.7% |
| 1Y | +499.5% | +40.1% | +459.4% | +430.8% |
| All | +499.5% | +38.4% | +461.1% | +430.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BTG.
Daily Out/Under-Performance
Portfolio return minus BTG return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BTG return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BTG wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling